These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


63 related items for PubMed ID: 9031577

  • 1. Nonpharmacological response in hospitalized children with conduct disorder.
    Malone RP, Luebbert JF, Delaney MA, Biesecker KA, Blaney BL, Rowan AB, Campbell M.
    J Am Acad Child Adolesc Psychiatry; 1997 Feb; 36(2):242-7. PubMed ID: 9031577
    [Abstract] [Full Text] [Related]

  • 2. Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study.
    Cueva JE, Overall JE, Small AM, Armenteros JL, Perry R, Campbell M.
    J Am Acad Child Adolesc Psychiatry; 1996 Apr; 35(4):480-90. PubMed ID: 8919710
    [Abstract] [Full Text] [Related]

  • 3. Placebo response in aggressive children with conduct disorder.
    Sanchez LE, Armenteros JL, Small AM, Campbell M, Adams PB.
    Psychopharmacol Bull; 1994 Apr; 30(2):209-13. PubMed ID: 7831457
    [Abstract] [Full Text] [Related]

  • 4. Aggression classification and treatment response.
    Malone RP, Bennett DS, Luebbert JF, Rowan AB, Biesecker KA, Blaney BL, Delaney MA.
    Psychopharmacol Bull; 1998 Apr; 34(1):41-5. PubMed ID: 9564197
    [Abstract] [Full Text] [Related]

  • 5. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.
    Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M.
    Arch Gen Psychiatry; 2000 Jul; 57(7):649-54. PubMed ID: 10891035
    [Abstract] [Full Text] [Related]

  • 6. Side effects associated with lithium and placebo administration in aggressive children.
    Silva RR, Campbell M, Golden RR, Small AM, Pataki CS, Rosenberg CR.
    Psychopharmacol Bull; 1992 Jul; 28(3):319-26. PubMed ID: 1480737
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 8. Electroencephalogram and treatment of hospitalized aggressive children with haloperidol or lithium.
    Bennett WG, Korein J, Kalmijn M, Grega DM, Campbell M.
    Biol Psychiatry; 1983 Dec; 18(12):1427-40. PubMed ID: 6362729
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R.
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [Abstract] [Full Text] [Related]

  • 10. Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study.
    Kafantaris V, Campbell M, Padron-Gayol MV, Small AM, Locascio JJ, Rosenberg CR.
    Psychopharmacol Bull; 1992 Mar; 28(2):193-9. PubMed ID: 1513924
    [Abstract] [Full Text] [Related]

  • 11. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 13. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
    Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ.
    Pediatr Nephrol; 2002 May; 17(5):345-50. PubMed ID: 12042891
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Overt Aggression Scale in a study of lithium in aggressive conduct disorder.
    Malone RP, Luebbert J, Pena-Ariet M, Biesecker K, Delaney MA.
    Psychopharmacol Bull; 1994 Sep; 30(2):215-8. PubMed ID: 7831458
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

  • 19. The effect of fish oil on physical aggression in schoolchildren--a randomized, double-blind, placebo-controlled trial.
    Itomura M, Hamazaki K, Sawazaki S, Kobayashi M, Terasawa K, Watanabe S, Hamazaki T.
    J Nutr Biochem; 2005 Mar; 16(3):163-71. PubMed ID: 15741051
    [Abstract] [Full Text] [Related]

  • 20. A double-blind pilot study of risperidone in the treatment of conduct disorder.
    Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL.
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):509-16. PubMed ID: 10761354
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.